Ensuring Continuity in Patient Insights to Strengthen Medicine Development

Ensuring Continuity in Patient Insights to Strengthen Medicine Development

About this podcast: 

This session was recorded at the March 2025 Patients as Partners conference. In this session, Pfizer addressed how they were working to ensure continuity in the patient insights they were collecting, throughout the product life cycle. This included: 
  • Approaches for aligning internal processes to facilitate the seamless flow of patient insights from early-phase to late-phase teams
  • Suggested tools, including an AI Insights tool designed to centralize and leverage previous patient feedback, supporting a more integrated approach to patient engagement
  • Strategies to build on existing insights, enhance collaboration across teams, and drive more effective patient-centered outcomes in R&D processes


For more information, go to PatientsAsPartnersConference.com.

Speakers
Stephanie Christopher
Patient Engagement Lead, R&D
Pfizer
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.